Turning Point Therapeutics Inc (TPTX)
NASDAQ:TPTX
US Market
Holding TPTX?
Track your performance easily

Turning Point Therapeutics (TPTX) Financial Statements

0 Followers

Turning Point Therapeutics Financial Overview

Turning Point Therapeutics's market cap is currently ―. The company's EPS TTM is $-6.903; its P/E ratio is -11.01; Turning Point Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement-
Total Revenue$ 119.00K$ 429.00K$ 0.00$ 460.00K$ 5.16M
Gross Profit-----
EBIT$ -124.36M$ -74.94M$ -78.64M$ -66.65M$ -56.66M
EBITDA$ -123.05M$ -73.68M$ -77.37M$ -65.44M$ -55.81M
Net Income Common Stockholders$ -123.09M$ -74.44M$ -78.45M$ -66.33M$ -56.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 711.39M$ 818.29M$ 918.19M$ 981.58M$ 1.04B
Total Assets$ 843.34M$ 938.79M$ 1.00B$ 1.06B$ 1.10B
Total Debt$ 2.25M$ 3.27M$ 3.39M$ 5.03M$ 5.92M
Net Debt$ -709.14M$ -815.02M$ -914.80M$ -976.55M$ -1.03B
Total Liabilities$ 50.31M$ 47.44M$ 49.04M$ 41.65M$ 35.41M
Stockholders Equity$ 701.59M$ 793.02M$ 891.35M$ 954.42M$ 1.02B
Cash Flow-
Free Cash Flow$ -106.83M$ -58.78M$ -54.54M$ -42.83M$ -43.15M
Operating Cash Flow$ -105.30M$ -58.33M$ -54.15M$ -41.66M$ -42.42M
Investing Cash Flow$ 76.94M$ -60.41M$ 75.22M$ 17.44M$ -8.27M
Financing Cash Flow$ 8.97M$ 396.00K$ 2.60M$ 2.38M$ 9.34M
Currency in USD

Turning Point Therapeutics Earnings and Revenue History

Turning Point Therapeutics Debt to Assets

Turning Point Therapeutics Cash Flow

Turning Point Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis